Karlan BY - Search Results

1

Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer.

Wolf I, Bose S, Desmond JC, Lin BT, Williamson EA, Karlan BY, Koeffler HP. Wolf I, et al. Among authors: karlan by. Breast Cancer Res Treat. 2007 Oct;105(2):139-55. doi: 10.1007/s10549-006-9440-4. Epub 2007 Feb 13. Breast Cancer Res Treat. 2007. PMID: 17295047

2

BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.

Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY. Baldwin RL, et al. Among authors: karlan by. Cancer Res. 2000 Oct 1;60(19):5329-33. Cancer Res. 2000. PMID: 11034065

3

Differential gene expression between normal and tumor-derived ovarian epithelial cells.

Ismail RS, Baldwin RL, Fang J, Browning D, Karlan BY, Gasson JC, Chang DD. Ismail RS, et al. Among authors: karlan by. Cancer Res. 2000 Dec 1;60(23):6744-9. Cancer Res. 2000. PMID: 11118061

4

Gene expression in epithelial ovarian carcinoma.

Matei D, Graeber TG, Baldwin RL, Karlan BY, Rao J, Chang DD. Matei D, et al. Among authors: karlan by. Oncogene. 2002 Sep 12;21(41):6289-98. doi: 10.1038/sj.onc.1205785. Oncogene. 2002. PMID: 12214269

5

Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility.

Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY, Chang DD. Gillan L, et al. Among authors: karlan by. Cancer Res. 2002 Sep 15;62(18):5358-64. Cancer Res. 2002. PMID: 12235007

6

Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells.

Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, Ayala R, Danino M, Karlan BY, Slamon DJ. Arboleda MJ, et al. Among authors: karlan by. Cancer Res. 2003 Jan 1;63(1):196-206. Cancer Res. 2003. PMID: 12517798

7

Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.

Baldwin RL, Tran H, Karlan BY. Baldwin RL, et al. Among authors: karlan by. Cancer Res. 2003 Mar 15;63(6):1413-9. Cancer Res. 2003. PMID: 12649207

8

BRCA1 promoter methylation predicts adverse ovarian cancer prognosis.

Chiang JW, Karlan BY, Cass L, Baldwin RL. Chiang JW, et al. Among authors: karlan by. Gynecol Oncol. 2006 Jun;101(3):403-10. doi: 10.1016/j.ygyno.2005.10.034. Epub 2005 Dec 19. Gynecol Oncol. 2006. PMID: 16360812

9

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.

Wolf I, O'Kelly J, Rubinek T, Tong M, Nguyen A, Lin BT, Tai HH, Karlan BY, Koeffler HP. Wolf I, et al. Among authors: karlan by. Cancer Res. 2006 Aug 1;66(15):7818-23. doi: 10.1158/0008-5472.CAN-05-4368. Cancer Res. 2006. PMID: 16885386

10

Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk.

Walsh CS, Miller CW, Karlan BY, Koeffler HP. Walsh CS, et al. Among authors: karlan by. Gynecol Oncol. 2007 Mar;104(3):660-4. doi: 10.1016/j.ygyno.2006.10.008. Epub 2006 Nov 21. Gynecol Oncol. 2007. PMID: 17123590

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

518 results

Search Page

Filters